TMFEBCapital

Todd Campbell

TMFEBCapital’s Activity

Sat Aug 20

NL

Article

EBCapitalMarkets published an article 10:40 AM

Why Edwards Lifesciences Could Be About to Soar

An FDA approval significantly expands the company's opportunity in treating aortic stenosis.

NL

Article

EBCapitalMarkets published an article 9:01 AM

3 High-Yielding Healthcare Stocks I'm Not Buying

Computer Programs & Systems, GlaxoSmithKline, and AstraZeneca's high dividend yields aren't as alluring as some might think.

Fri Aug 19

NL

Article

EBCapitalMarkets published an article 4:01 PM

5 Things You Better Know About Social Security

Most Americans will receive Social Security. However, many Americans don't understand how this program works.

Thu Aug 18

NL

Article

EBCapitalMarkets published an article 4:40 PM

Is It "Game Over" After Portola's FDA Rejection?

The FDA has surprisingly rejected approval of the company's AndexXa, leaving investors uncertain about the drug's future.

NL

Article

EBCapitalMarkets published an article 2:07 PM

Why Accuray Incorporated Is Tumbling 12.5% Today

Fiscal fourth-quarter financials did little to reignite enthusiasm in the cancer treatment company.

NL

Article

EBCapitalMarkets published an article 1:28 PM

What Caused Arrowhead Pharmaceuticals to Skyrocket 12.5% Today

A vote of confidence from Cantor Fitzgerald is igniting investor interest.

NL

Article

EBCapitalMarkets published an article 9:23 AM

3 High-Yield ETFs to Buy Today

These exchange-traded funds have the possibility of yielding income investors some additional pop.

Wed Aug 17

NL

Article

EBCapitalMarkets published an article 3:18 PM

Aetna Makes Good on Its Threat, Exits Obamacare

The insurer warned regulators last month that blocking its planned merger with Humana would force it to abandon the Obamacare exchanges, and now it's following through on its promise.

NL

Article

EBCapitalMarkets published an article 10:23 AM

Warren Buffett's Most Significant New Sells

Wal-Mart and Suncor Energy fell out of favor with the iconic long-term investor during the second quarter.

Tue Aug 16

NL

Article

EBCapitalMarkets published an article 3:09 PM

Warren Buffett's Most Significant Stock Buys

The Oracle of Omaha manages one of the biggest equity portfolios on the planet, and last quarter he stepped up and boosted his positions in Apple and Phillips 66.

NL

Article

EBCapitalMarkets published an article 1:22 PM

Aetna's Exit Puts Obamacare's Future on Even Shakier Ground

A decision by Aetna to stop offering plans in most states further reduces competition, and that could cause plan premiums to spike.

NL

Article

EBCapitalMarkets published an article 11:23 AM

10 Highest Healthcare Dividend Stocks

These 10 healthcare dividend stocks offer plenty of income potential, but risks make only two worth buying.

Sat Aug 13

NL

Article

EBCapitalMarkets published an article 12:02 PM

Did the DEA Just Give These Marijuana Companies a Big Break?

A decision to keep marijuana a Schedule 1 drug may keep a lid on cannabis research.

NL

Article

EBCapitalMarkets published an article 8:40 AM

Where Gary Johnson Stands on Social Security

Social Security's future is in jeopardy. Here's how Gary Johnson plans to fix the ailing entitlement program.

NL

Article

EBCapitalMarkets published an article 8:05 AM

3 Brilliant Roth IRA Strategies

Roth IRAs offer more investment planning options than you might think.

Fri Aug 12

NL

Article

EBCapitalMarkets published an article 6:05 PM

Medicare Negotiating of Drug Prices May Not Be the Cure to High Costs

Innovative cost-cutting solutions may help Medicare crimp costs more than negotiating directly with drugmakers.

NL

Article

EBCapitalMarkets published an article 12:00 AM

Bristol-Myers' Revolutionary Cancer Drug Suffers A Big Blow

Bristol-Myers Squibb's Opdivo came up short in a key lung cancer trial, causing shares to plummet. Should investors panic?

Thu Aug 11

NL

Article

EBCapitalMarkets published an article 6:40 PM

This "Cheap" Stock May Not Be a Bargain

Cuts to sales and profit guidance could make Impax Labs' shares more expensive relative to earnings than they appear.

NL

Article

EBCapitalMarkets published an article 5:00 PM

Could Gilead Sciences Face an Unexpected $10 Billion Tax Bill?

A tax advocacy group is lobbying the IRS to look into Gilead Sciences' overseas profits.

NL

Article

EBCapitalMarkets published an article 2:03 PM

3 Under-the-Radar Healthcare Stocks You've Never Heard of

Do upstarts Exact Sciences, Portola Pharmaceuticals, and Abiomed deserve a place in portfolios?

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating 38.16
Player Rank 46337 out of 74932
Score -24.28
Score Change Today -5.56
Accuracy 38.89%
Active Picks 36
Total Picks 36
Best Pick MDVN (+141.30)
Worst Pick WFM (-71.98)
Average Score per Pick -0.67
Charms Earned 6
Highest Rated Favorite No Favorites Selected
Go to TMFEBCapital’s CAPS page

Boards Stats & Trivia

Board Posts 0
Recs Received 0
People who have rec'd these posts 0
Recs to Posts Ratio (last 30 days) N/A
Threads Started 0
Threads Started Percentage 0.00 %
Most Frequent Board N/A
Very First Post N/A
Percentage of Posts Rec'd 100.00 %
Show TMFEBCapital’s 10 Latest Posts